NCT03977272 2023-01-27Combination of Anti-PD-1 Antibody and Chemotherapy in Metastatic Pancreatic CancerZhejiang UniversityPhase 2 Completed110 enrolled
NCT04125693 2022-04-01Roll-over Study to Continue Treatment With the Investigational Drug Rogaratinib and to Further Test Its SafetyBayerPhase 2 Completed1 enrolled